Toracchio L, Carrabotta M, Mancarella C, Morrione A, Scotlandi K
Int J Mol Sci. 2024; 25(22).
PMID: 39596256
PMC: 11594831.
DOI: 10.3390/ijms252212191.
Xu S, Zheng Y, Ye M, Shen T, Zhang D, Li Z
BMC Cancer. 2024; 24(1):1064.
PMID: 39198775
PMC: 11351591.
DOI: 10.1186/s12885-024-12843-0.
Ebrahim T, Ebrahim A, Kandouz M
Cells. 2024; 13(6.
PMID: 38534339
PMC: 10969453.
DOI: 10.3390/cells13060495.
Stergiou I, Papadakos S, Karyda A, Tsitsilonis O, Dimopoulos M, Theocharis S
Cancers (Basel). 2023; 15(15).
PMID: 37568780
PMC: 10417178.
DOI: 10.3390/cancers15153963.
Verma M, Chopra M, Kumar H
Cell Mol Neurobiol. 2023; 43(7):3375-3391.
PMID: 37477786
PMC: 11409998.
DOI: 10.1007/s10571-023-01390-0.
Physiological and pathophysiological mechanisms of the molecular and cellular biology of angiogenesis and inflammation in moyamoya angiopathy and related vascular diseases.
Dorschel K, Wanebo J
Front Neurol. 2023; 14:661611.
PMID: 37273690
PMC: 10236939.
DOI: 10.3389/fneur.2023.661611.
EphrinB2-EphB4 Signaling in Neurooncological Disease.
Piffko A, Uhl C, Vajkoczy P, Czabanka M, Broggini T
Int J Mol Sci. 2022; 23(3).
PMID: 35163601
PMC: 8836162.
DOI: 10.3390/ijms23031679.
EphA2 signaling within integrin adhesions regulates fibrillar adhesion elongation and fibronectin deposition.
Finney A, Scott M, Reeves K, Wang D, Alfaidi M, Schwartz J
Matrix Biol. 2021; 103-104:1-21.
PMID: 34537369
PMC: 8599653.
DOI: 10.1016/j.matbio.2021.09.001.
The Value of EphB2 Receptor and Cognate Ephrin Ligands in Prognostic and Predictive Assessments of Human Breast Cancer.
Ebrahim A, Hailat Z, Bandyopadhyay S, Neill D, Kandouz M
Int J Mol Sci. 2021; 22(15).
PMID: 34360867
PMC: 8348398.
DOI: 10.3390/ijms22158098.
Cell-Extrinsic Differentiation Block Mediated by EphA3 in Pre-Leukaemic Thymus Contributes to Disease Progression.
Pliego Zamora A, Ranasinghe H, Lisle J, Ng C, Huang S, Wadlow R
Cancers (Basel). 2021; 13(15).
PMID: 34359759
PMC: 8345401.
DOI: 10.3390/cancers13153858.
Coexpression of EphA10 and Gli3 promotes breast cancer cell proliferation, invasion and migration.
Peng J, Zhang D
J Investig Med. 2021; 69(6):1215-1221.
PMID: 33990369
PMC: 8327407.
DOI: 10.1136/jim-2021-001836.
Cerebrovascular development: mechanisms and experimental approaches.
Chico T, Kugler E
Cell Mol Life Sci. 2021; 78(9):4377-4398.
PMID: 33688979
PMC: 8164590.
DOI: 10.1007/s00018-021-03790-1.
Role of tyrosine kinases in bladder cancer progression: an overview.
Zangouei A, Barjasteh A, Rahimi H, Mojarrad M, Moghbeli M
Cell Commun Signal. 2020; 18(1):127.
PMID: 32795296
PMC: 7427778.
DOI: 10.1186/s12964-020-00625-7.
The prognostic value of ephrin type-A2 receptor and Ki-67 in renal cell carcinoma patients: An Immunohistochemical and Bioinformatical Approach; A STROBE - compliant article.
Talaat I, Okap I, Abou Youssif T, Hachim I, Hachim M, Sheikh S
Medicine (Baltimore). 2020; 99(19):e20191.
PMID: 32384514
PMC: 7220257.
DOI: 10.1097/MD.0000000000020191.
Digenic inheritance of mutations in EPHA2 and SLC26A4 in Pendred syndrome.
Li M, Nishio S, Naruse C, Riddell M, Sapski S, Katsuno T
Nat Commun. 2020; 11(1):1343.
PMID: 32165640
PMC: 7067772.
DOI: 10.1038/s41467-020-15198-9.
EphA10 and EphB3 are prognostic markers in gallbladder squamous cell/adenosquamous carcinomas and adenocarcinomas.
Yan H, Li Q, Cai W, Tang D, Wang B, Liu X
Int J Clin Exp Pathol. 2020; 11(2):512-525.
PMID: 31938137
PMC: 6958000.
Hypoxia-induced EPHB2 promotes invasive potential of glioblastoma.
Qiu W, Song S, Chen W, Zhang J, Yang H, Chen Y
Int J Clin Exp Pathol. 2020; 12(2):539-548.
PMID: 31933858
PMC: 6945092.
A morphogenetic EphB/EphrinB code controls hepatopancreatic duct formation.
Thestrup M, Caviglia S, Cayuso J, Heyne R, Ahmad R, Hofmeister W
Nat Commun. 2019; 10(1):5220.
PMID: 31745086
PMC: 6864101.
DOI: 10.1038/s41467-019-13149-7.
Tumor angiogenesis: causes, consequences, challenges and opportunities.
Lugano R, Ramachandran M, Dimberg A
Cell Mol Life Sci. 2019; 77(9):1745-1770.
PMID: 31690961
PMC: 7190605.
DOI: 10.1007/s00018-019-03351-7.
Immunohistochemical assessment of Eph/ephrin expression in oral squamous cell carcinoma and precursor lesions.
Saito H, Oikawa M, Kouketsu A, Takahashi T, Kumamoto H
Odontology. 2019; 108(2):166-173.
PMID: 31654153
DOI: 10.1007/s10266-019-00466-y.